Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Tarantini

Showing results (531-540 of 622) with videos related to

Pageof 63
Sort By:
Trials|November 25, 2020
Downstream or upstream administration of P2Y12 receptor blockers in non-ST elevated acute coronary syndromes: study protocol for a randomized controlled trialGiuseppe Tarantini, Marco Mojoli, Ferdinando Varbella, et al.
European Heart Journal|June 1, 2021
Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI)Heerajnarain Bulluck, Valeria Paradies, Emanuele Barbato, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 30, 2025
The Impact of THV Platforms on Transfemoral TAVR in Complex Vascular Access: Insights From the Hostile RegistryChiara Fraccaro, Tullio Palmerini, Giulia Lorenzoni, et al.
Circulation. Cardiovascular Interventions|November 21, 2023
Feasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation StudyGilbert H L Tang, Julianne Spencer, Toby Rogers, et al.
European Journal of Haematology|September 16, 2025
Efficacy of Momelotinib in Myelofibrosis Patients: Results From a Multicenter StudyMaria Carmen Martorelli, Novella Pugliese, Maria Di Perna, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 30, 2025
Mechanical circulatory support in high-risk elective PCI: rationale and design of the PROTECT IV trialNorman Mangner, Samin K Sharma, Chris O'Connor, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 26, 2023
Predictors of target lesion failure after treatment of left main, bifurcation, or chronic total occlusion lesions with ultrathin-strut drug-eluting coronary stents in the ULTRA registryOvidio de Filippo, Francesco Bruno, Tineke H Pinxterhuis, et al.
International Journal of Cardiology|August 2, 2023
Transcatheter aortic valve replacement with the self-expanding ACURATE Neo2 in patients with horizontal aorta: Insights from the ITAL-neo registryMonica Barki, Alfonso Ielasi, Andrea Buono, et al.
Blood Advances|June 5, 2023
A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphomaAnnalisa Arcari, Lugi Rigacci, Alessandra Tucci, et al.
Annals of Hematology|October 10, 2025
Single versus double autologous stem cell transplantation and lenalidomide maintenance versus no maintenance therapy in newly-diagnosed patients with multiple myeloma: a real-life, vintage snapshot after twenty-three years from the Rete Ematologica PuglieseNicola Di Renzo, Emanuela Resta, Michelina Dargenio, et al.
Pageof 63

Showing results (531-540 of 622) with videos related to

Sort By:
Pageof 63
Trials|November 25, 2020
Downstream or upstream administration of P2Y12 receptor blockers in non-ST elevated acute coronary syndromes: study protocol for a randomized controlled trialGiuseppe Tarantini, Marco Mojoli, Ferdinando Varbella, et al.
European Heart Journal|June 1, 2021
Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI)Heerajnarain Bulluck, Valeria Paradies, Emanuele Barbato, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 30, 2025
The Impact of THV Platforms on Transfemoral TAVR in Complex Vascular Access: Insights From the Hostile RegistryChiara Fraccaro, Tullio Palmerini, Giulia Lorenzoni, et al.
Circulation. Cardiovascular Interventions|November 21, 2023
Feasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation StudyGilbert H L Tang, Julianne Spencer, Toby Rogers, et al.
European Journal of Haematology|September 16, 2025
Efficacy of Momelotinib in Myelofibrosis Patients: Results From a Multicenter StudyMaria Carmen Martorelli, Novella Pugliese, Maria Di Perna, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 30, 2025
Mechanical circulatory support in high-risk elective PCI: rationale and design of the PROTECT IV trialNorman Mangner, Samin K Sharma, Chris O'Connor, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 26, 2023
Predictors of target lesion failure after treatment of left main, bifurcation, or chronic total occlusion lesions with ultrathin-strut drug-eluting coronary stents in the ULTRA registryOvidio de Filippo, Francesco Bruno, Tineke H Pinxterhuis, et al.
International Journal of Cardiology|August 2, 2023
Transcatheter aortic valve replacement with the self-expanding ACURATE Neo2 in patients with horizontal aorta: Insights from the ITAL-neo registryMonica Barki, Alfonso Ielasi, Andrea Buono, et al.
Blood Advances|June 5, 2023
A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphomaAnnalisa Arcari, Lugi Rigacci, Alessandra Tucci, et al.
Annals of Hematology|October 10, 2025
Single versus double autologous stem cell transplantation and lenalidomide maintenance versus no maintenance therapy in newly-diagnosed patients with multiple myeloma: a real-life, vintage snapshot after twenty-three years from the Rete Ematologica PuglieseNicola Di Renzo, Emanuela Resta, Michelina Dargenio, et al.
Pageof 63